Major trial tests promising new drug for Tough-to-Treat uterine cancer
NCT ID NCT07286331
Summary
This large, late-stage study aims to find out if a new drug called GSK5733584 works better and is safer than standard chemotherapy for women whose endometrial cancer has returned. It will enroll about 600 participants whose cancer has come back after prior treatment. The main goals are to see if the new drug shrinks tumors more effectively and helps patients live longer without their cancer getting worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOPLASMS, ENDOMETRIAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.